Skip to content

2025

  • 7 min read

H1 2025 Platform Update: AI-Driven Insights, Phenotypic AMR Prediction, Advanced Fungal Genomics, and Next-Generation Surveillance Tools from BugSeq

The first half of 2025 marked a significant leap forward for the BugSeq platform, delivering powerful new capabilities to tackle the most pressing challenges in infectious disease. We’re introducing AI-powered report summaries to accelerate interpretation, leading accuracy AMR phenotype prediction (coming in a separate blog post), advanced fungal diagnostics to combat emerging pathogens, and next-generation surveillance tools that fuse genomic and epidemiological data. These updates are engineered to empower laboratories with deeper insights, greater accuracy, and faster time to action.

  • 4 min read

Data-Driven Infection Control Using BugSeq’s Isolate Clustering and Insights

Infection control poses a daunting challenge for clinical microbiology labs: pathogens are constantly evolving, and outbreaks can spread with alarming speed. Timely, accurate insights are the key to staying ahead, preventing outbreaks before they happen and rapidly mitigating them when they do. BugSeq’s Infection Control solutions currently help hundreds of labs be proactive about infection control. By harnessing advanced clustering methods and real-time insights, we empower laboratories and healthcare facilities to detect, track, and prevent the spread of infectious diseases more efficiently than ever.

  • 5 min read

Supporting Bioinformatics in a Regulated Environment

Next-generation sequencing is enabling a new paradigm of microbiology assays within the clinical and public health laboratory. These assays are enabling identification of microorganisms from culture or directly from sample, study of antimicrobial resistance, and investigation of relatedness between isolates.While many of these assays are used for surveillance purposes, with global changes to many regulatory frameworks, there is a growing need for assays that can be used in a regulated environment. BugSeq is invested in enabling reporting from our results to improve human health. Below, we detail some of the unique capabilities of BugSeq to enable integration into mission-critical assays.